This inventor holds 1 USPTO granted patent. Top assignee: USA as Represented by Secretary of the Navy. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: John P Chute: Innovator in Stem Cell Expansion
Introduction
John P Chute is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of stem cell research, particularly in the expansion of primitive bone marrow stem cells. His innovative work has implications for medical advancements and therapeutic applications.
Latest Patents
John P Chute holds a patent for a novel co-culture system using human brain endothelial cells (HUBEC). This system promotes the expansion of human CD34 CD38 cells, which are crucial for various medical treatments. The patent details the isolation of HUBEC from cadaveric donors and their cultivation, resulting in remarkable increases in total cells and specific stem cell populations. The findings indicate a 14.5-fold increase in total cells, a 6.6-fold increase in CD34 cells, and an impressive 440-fold increase in CD34 CD38 cells after just seven days. The optimal generation of these cells relies on the continuous presence of supplied cytokines.
Career Highlights
John P Chute is associated with the United States Navy, where he contributes his expertise in stem cell research. His work has been instrumental in advancing the understanding of human stem cells and their potential applications in medicine.
Collaborations
Throughout his career, John has collaborated with notable colleagues, including Abha A Saini and Dennis J Chute. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
John P Chute's contributions to stem cell research and his innovative patent highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile